MAPK7 and glioblastoma: Previous studies indicated that ERK5 expressed by GSCs plays a critical role in maintaining stemness and tumorigenicity in GSCs; thus, we assessed whether ERK5 in patients with GBM harboring higher stem cell properties is associated with poor prognosis.